Abstract
Background and Aims: Familial Hypercholesterolemia (FH) is characterized by high LDL-cholesterol levels and high cardiovascular risk, being caused by mutations in LDLR, APOB, PCSK9, APOE, STAP1 or LDLRAP1 genes. The European Atherosclerosis Society (EAS) has recommended some criteria of clinical suspicion, but their sensitivity and efficiency have not been studied.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
